World Asset Management Inc - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
World Asset Management Inc ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2019$346,000
-3.6%
9,733
-8.9%
0.02%
-5.6%
Q1 2019$359,000
-0.3%
10,682
-2.4%
0.02%
-18.2%
Q4 2018$360,000
-48.0%
10,950
-3.6%
0.02%
-33.3%
Q3 2018$692,000
+33.1%
11,356
+6.7%
0.03%
+32.0%
Q2 2018$520,000
-46.4%
10,646
+16.6%
0.02%
-44.4%
Q1 2018$970,000
+78.6%
9,133
+0.5%
0.04%
+150.0%
Q4 2017$543,000
+119.8%
9,088
-11.6%
0.02%
+125.0%
Q3 2017$247,000
+24.1%
10,281
+1.1%
0.01%
+14.3%
Q2 2017$199,000
-11.9%
10,167
+5.6%
0.01%0.0%
Q1 2017$226,000
+79.4%
9,628
-11.9%
0.01%
+133.3%
Q2 2013$126,00010,9300.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2018
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders